AINDEX
Markets

Clinuvel Pharmaceuticals Limited (CUVL)

CUVLNASDAQ-GSMiscellaneous

$4.90

-0.0700 (-1.41%) today

Closed, Nov 17, 4:00 PM ET

-1.41% 1D
Market cap
$252.14m
P/E
–
EPS, last 4 quarters
–
Dividend yield
0.71%
Day range
–
52-week range
$4.81 to $8.20
Average volume
–
Previous close
$4.97

Financials

No quarterly figures from the source.

News

1 latest

The company

CLINUVEL is a global biopharmaceutical company focused on developing and delivering innovative therapies for patients with genetic, metabolic, and dermatological disorders. The Company's portfolio is centred around melanocortin peptides, with programs advancing in photomedicine and vitiligo. CLINUVEL is listed on the Australian Securities Exchange (ASX: CUV) and the Nasdaq Stock Market (Nasdaq: CUVL).

Sector
Miscellaneous
Industry
Miscellaneous
Exchange
NASDAQ-GS
Region
Australia and South Pacific

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.